Press Releases

Number of shares and votes in Active Biotech
December 30, 2010 08:30 (CET)
TEVA ANNOUNCES SUCCESSFUL RESULTS OF PHASE III STUDY WITH ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS
December 9, 2010 07:30 (CET)
Orphan Medicinal Product Status to Active Biotech's 57-57 project recommended
November 18, 2010 10:08 (CET)
Active Biotech's election committee appointed
November 3, 2010 14:00 (CET)
Number of shares and votes in Active Biotech
October 29, 2010 08:30 (CEST)
Active Biotech AB Interim Report January - September 2010
October 27, 2010 08:30 (CEST)
NEW DATA EVALUATING LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS DEMONSTRATE NEUROPROTECTIVE EFFECTS
October 15, 2010 15:30 (CEST)
Number of shares and votes in Active Biotech
September 30, 2010 08:30 (CEST)
ORAL LAQUINIMOD DEMONSTRATED SUSTAINED EFFICACY AND SAFETY IN PATIENTS WITH MULTIPLE SCLEROSIS
September 20, 2010 15:00 (CEST)
Active Biotech to Present at the UBS Global Life Sciences Conference
September 16, 2010 08:30 (CEST)